Literature DB >> 24477713

Clinical features of pediatric nonalcoholic fatty liver disease: a need for increased awareness and a consensus for screening.

Jeremy P Middleton1, R Constance Wiener2, Barrett H Barnes1, Matthew J Gurka2, Mark D DeBoer3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24477713      PMCID： PMC4450252          DOI： 10.1177/0009922813520072

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN： 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  70 in total

1.  Ethnic differences in the link between insulin resistance and elevated ALT.

Authors:  Mark D Deboer; R Constance Wiener; Barrett H Barnes; Matthew J Gurka
Journal:  Pediatrics       Date:  2013-08-12       Impact factor: 7.124

2.  Rosiglitazone and cardiovascular risk.

Authors:  Edoardo Mannucci; Matteo Monami; Niccolò Marchionni
Journal:  N Engl J Med       Date:  2007-08-30       Impact factor: 91.245

3.  A feed-forward loop amplifies nutritional regulation of PNPLA3.

Authors:  Yongcheng Huang; Shaoqing He; John Zhong Li; Young-Kyo Seo; Timothy F Osborne; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

4.  Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents.

Authors:  Jeffrey B Schwimmer; Nancy McGreal; Reena Deutsch; Milton J Finegold; Joel E Lavine
Journal:  Pediatrics       Date:  2005-05       Impact factor: 7.124

Review 5.  Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Authors:  Kenneth Cusi
Journal:  Gastroenterology       Date:  2012-02-08       Impact factor: 22.682

Review 6.  Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.

Authors:  Donna L White; Fasiha Kanwal; Hashem B El-Serag
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-04       Impact factor: 11.382

7.  Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers.

Authors:  Indra Neil Guha; Julie Parkes; Paul Roderick; Dipanker Chattopadhyay; Richard Cross; Scott Harris; Philip Kaye; Alastair D Burt; Steve D Ryder; Guruprasad P Aithal; Christopher P Day; William M Rosenberg
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

8.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

9.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

10.  Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004.

Authors:  Abigail Fraser; Matthew P Longnecker; Debbie A Lawlor
Journal:  Gastroenterology       Date:  2007-09-02       Impact factor: 22.682
View more
  3 in total

1.  Serum Alanine Aminotransferase Trends and Their Relationship with Obesity and Metabolic Syndrome in United States Adolescents, 1999-2014.

Authors:  Cyrelle R Fermin; Arthur M Lee; Stephanie L Filipp; Matthew J Gurka; Mark D DeBoer
Journal:  Metab Syndr Relat Disord       Date:  2017-05-18       Impact factor: 1.894

Review 2.  Pediatric Type 2 Diabetes: Not a Mini Version of Adult Type 2 Diabetes.

Authors:  Talia Alyssa Savic Hitt; Lorraine E Levitt Katz
Journal:  Endocrinol Metab Clin North Am       Date:  2020-10-14       Impact factor: 4.741

3.  Normal range of hepatic fat fraction on dual- and triple-echo fat quantification MR in children.

Authors:  Hyun Joo Shin; Hyun Gi Kim; Myung-Joon Kim; Hong Koh; Ha Yan Kim; Yun Ho Roh; Mi-Jung Lee
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.